European Commission Approves Upadacitinib for Psoriatic Arthritis & Ankylosing Spondylitis
Risankizumab May Improve Symptoms of PsA
Study Shows Psoriatic Arthritis Impacts Women More Than Men
FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis
Guselkumab Approved for PsA
2 Pediatric Indications Sought for Golimumab
Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis
Risankizumab & Apremilast Come to Market in Canada
Tildrakizumab Promising for Psoriasis in Patients with PsA
- 1
- 2
- 3
- …
- 12
- Next Page »